Search for new anti-mycobacterial substances using established assay system focusing on the environments of infected region, and analysis of target molecule for development of new drug targets
Project/Area Number |
21310143
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Living organism molecular science
|
Research Institution | Osaka University |
Principal Investigator |
ARAI Masayoshi 大阪大学, 大学院・薬学研究科, 准教授 (80311231)
|
Co-Investigator(Kenkyū-buntansha) |
KOBAYASHI Motomasa 大阪大学, 大学院・薬学研究科, 教授 (40116033)
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥18,070,000 (Direct Cost: ¥13,900,000、Indirect Cost: ¥4,170,000)
Fiscal Year 2011: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2010: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2009: ¥6,760,000 (Direct Cost: ¥5,200,000、Indirect Cost: ¥1,560,000)
|
Keywords | 感染症 / 結核 / 活性天然物 / ケミカルバイオロジー / 海綿 / 海洋微生物 / 抗生物質 / バイオテクノロジー |
Research Abstract |
To explore new medicinal leads for Tuberculosis, we succeeded in establishment of the screening systems focusing on the environments of Mycobacterium tuberculosis-infected region. Then, we searched the active substances from the extracts of marine organisms and the culture of marine microbe by established bioassay-guided separation. As a result, we isolated halicyclamins, trichoderins and nybomysin as anti-dormant mycobacterial substances. In addition, we succeeded in choosing the candidates of their target molecules by using genomic DNA library and/ or next-generation sequencer. On the other hand, desferrioxamine E was identified as an inhibitor of biofilm formation of Mycobacterium species. We also clarified the action-mechanism of desferrioxamine E as an inhibitor of biofilm formation.
|
Report
(4 results)
Research Products
(49 results)